Genoray Statistics

Total Valuation

Genoray has a market cap or net worth of KRW 73.32 billion. The enterprise value is 87.71 billion.

Market Cap	73.32B
Enterprise Value	87.71B

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Genoray has 13.40 million shares outstanding. The number of shares has decreased by -1.87% in one year.

Current Share Class	n/a
Shares Outstanding	13.40M
Shares Change (YoY)	-1.87%
Shares Change (QoQ)	-5.64%
Owned by Insiders (%)	29.19%
Owned by Institutions (%)	1.11%
Float	9.38M

Valuation Ratios

The trailing PE ratio is 9.69.

PE Ratio	9.69
Forward PE	n/a
PS Ratio	0.68
PB Ratio	0.79
P/TBV Ratio	0.80
P/FCF Ratio	21.86
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.01, with an EV/FCF ratio of 26.16.

EV / Earnings	11.49
EV / Sales	0.80
EV / EBITDA	5.01
EV / EBIT	8.14
EV / FCF	26.16

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.32.

Current Ratio	2.30
Quick Ratio	0.72
Debt / Equity	0.32
Debt / EBITDA	1.69
Debt / FCF	8.80
Interest Coverage	12.18

Financial Efficiency

Return on equity (ROE) is 8.13% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	8.13%
Return on Assets (ROA)	5.24%
Return on Capital (ROIC)	5.74%
Revenue Per Employee	314.93M
Profits Per Employee	22.06M
Employee Count	346
Asset Turnover	0.85
Inventory Turnover	1.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.56%
50-Day Moving Average	5,805.00
200-Day Moving Average	6,202.85
Relative Strength Index (RSI)	38.03
Average Volume (20 Days)	26,912

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genoray had revenue of KRW 108.97 billion and earned 7.63 billion in profits. Earnings per share was 564.44.

Revenue	108.97B
Gross Profit	40.85B
Operating Income	10.78B
Pretax Income	7.38B
Net Income	7.63B
EBITDA	17.51B
EBIT	10.78B
Earnings Per Share (EPS)	564.44

Full Income Statement

Balance Sheet

The company has 15.14 billion in cash and 29.52 billion in debt, giving a net cash position of -14.38 billion or -1,072.55 per share.

Cash & Cash Equivalents	15.14B
Total Debt	29.52B
Net Cash	-14.38B
Net Cash Per Share	-1,072.55
Equity (Book Value)	93.01B
Book Value Per Share	6,897.72
Working Capital	42.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.16 billion and capital expenditures -3.81 billion, giving a free cash flow of 3.35 billion.

Operating Cash Flow	7.16B
Capital Expenditures	-3.81B
Free Cash Flow	3.35B
FCF Per Share	250.18

Full Cash Flow Statement

Margins

Gross margin is 37.49%, with operating and profit margins of 9.89% and 7.01%.

Gross Margin	37.49%
Operating Margin	9.89%
Pretax Margin	6.77%
Profit Margin	7.01%
EBITDA Margin	16.07%
EBIT Margin	9.89%
FCF Margin	3.08%

Dividends & Yields

This stock pays an annual dividend of 160.00, which amounts to a dividend yield of 2.93%.

Dividend Per Share	160.00
Dividend Yield	2.93%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.62%
Buyback Yield	1.87%
Shareholder Yield	4.79%
Earnings Yield	10.32%
FCF Yield	4.57%

Dividend Details

Stock Splits

The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.

Last Split Date	Feb 21, 2020
Split Type	Forward
Split Ratio	3

Scores

Genoray has an Altman Z-Score of 3.64.

Altman Z-Score	3.64
Piotroski F-Score	n/a